Review Article​

​

Year: 2023 I Volume: 5 I Issue: 2 I Pages I 1- 4

 https://doi.org/10.46982/gjmt.2023.103

​

Unconventional Effector Cells in Cancer Therapy: A Narrative Review

​

Nagwa Ibrahim 1

​​

1 Global Healthcare Activities S.R.L, Cluj Napoca, Romania

​

* Corresponding Author:

​

Nagwa Ibrahim, Pharm D, PhD

Email address: nag_ibrahim@hotmail.com 

​

Source of funding:  None

 

Conflict of interest: None

​

Submission date: 8 May 2023

​

Acceptance date: 15 June 2023

​

Get permission for commercial use.

​

Key words: Immunotherapy, unconventional effector cells, cancer therapy, oncology, cancer

​

​​

Abstract:

​

Cancer immunotherapy has revolutionized the field of oncology by harnessing the power of the immune system to target and eliminate cancer cells. Traditional immunotherapeutic approaches have primarily focused on activating and enhancing the activity of conventional immune cells, such as T cells and natural killer (NK) cells. However, recent advances in cancer immunotherapy have explored the use of unconventional effector cells, which possess unique characteristics and capabilities that make them attractive candidates for targeting cancer. This review aims to provide an overview about unconventional effector cells in cancer therapy, highlighting their potential advantages, challenges, and future prospects.

​

​